GlassScriptPhysician profile
Shirley Joo
NPI 1144262825
$1,026.93
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Allergy & Immunology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $407 · 2020: $49.92 · 2021: $11.76 · 2022: $144 · 2023: $279 · 2024: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $262.68 | 2019-2024 | Tezspire, Fasenra, Breztri |
| Glaxosmithkline, LLC. | $180.31 | 2019-2024 | Nucala |
| Genentech USA, INC. | $113.89 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $106.88 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $99.14 | 2019-2024 | Dupixent |
| Optinose US, INC. | $73.89 | 2019-2023 | |
| Kaleo, INC. | $57.90 | 2019-2023 | Auvi-Q |
| Genzyme Corporation | $41.64 | 2023-2024 | |
| Pfizer INC. | $33.82 | 2019-2021 | |
| Alk-Abello, INC | $19.74 | 2019 | |
| Promius Pharma LLC | $12.93 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.17 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shirley Joo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.